Cargando…

Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial

BACKGROUND: Temporomandibular disorder (TMD) affects multiple tissues of the temporomandibular joint complex and manifests as orofacial pain and functional disturbance. While thread embedding acupuncture (TEA) is used for the treatment of TMD in clinical practice, sufficient clinical evidence is lac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung-Hyun, Kang, Dahae, Kim, Koh-Woon, Nam, Sang-Soo, Goo, Bonhyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576803/
https://www.ncbi.nlm.nih.gov/pubmed/36267351
http://dx.doi.org/10.2147/JPR.S383965
_version_ 1784811612987719680
author Kim, Jung-Hyun
Kang, Dahae
Kim, Koh-Woon
Nam, Sang-Soo
Goo, Bonhyuk
author_facet Kim, Jung-Hyun
Kang, Dahae
Kim, Koh-Woon
Nam, Sang-Soo
Goo, Bonhyuk
author_sort Kim, Jung-Hyun
collection PubMed
description BACKGROUND: Temporomandibular disorder (TMD) affects multiple tissues of the temporomandibular joint complex and manifests as orofacial pain and functional disturbance. While thread embedding acupuncture (TEA) is used for the treatment of TMD in clinical practice, sufficient clinical evidence is lacking. This pilot trial will explore the feasibility of a confirmatory randomized controlled trial (RCT) by considering the efficacy, safety, and cost-effectiveness of TEA to address pain, function, and quality of life in patients with TMD. METHODS: This randomized, assessor-blinded, controlled trial will include two parallel arms. Thirty patients with TMD and temporomandibular joint pain more severe than 40 mm on the 100-mm visual analog scale (VAS) and aged 19–70 years will be recruited and randomly allocated to either TEA or usual care groups. The TEA group will receive treatment at 14 predefined acupoints once weekly for 4 weeks. The usual care group will receive physical therapy consisting of transcutaneous electrical nerve stimulation and infrared therapy. The average VAS score over the last week for temporomandibular pain after four sessions will be assessed as the primary outcome. Furthermore, maximum pain VAS, vertical opening movement, Graded Chronic Pain version 2, Jaw Functional Limitation Scale 20, Patient Global Impression of Change, Korean version of Beck’s Depression Index, Short Form-12 Health Survey, EuroQol 5-Dimension 5-level, treatment expectation, rescue medication consumption, adverse events, and medical costs for economic evaluation will be measured and analyzed as secondary outcomes during four follow-up visits and after the termination of all sessions. CONCLUSION: The results of this trial will help evaluate the feasibility of a confirmatory RCT considering efficacy, safety, and cost-effectiveness and verify the effect size required to determine an appropriate sample size. TRIAL REGISTRATION NUMBER: KCT0007421.
format Online
Article
Text
id pubmed-9576803
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95768032022-10-19 Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial Kim, Jung-Hyun Kang, Dahae Kim, Koh-Woon Nam, Sang-Soo Goo, Bonhyuk J Pain Res Study Protocol BACKGROUND: Temporomandibular disorder (TMD) affects multiple tissues of the temporomandibular joint complex and manifests as orofacial pain and functional disturbance. While thread embedding acupuncture (TEA) is used for the treatment of TMD in clinical practice, sufficient clinical evidence is lacking. This pilot trial will explore the feasibility of a confirmatory randomized controlled trial (RCT) by considering the efficacy, safety, and cost-effectiveness of TEA to address pain, function, and quality of life in patients with TMD. METHODS: This randomized, assessor-blinded, controlled trial will include two parallel arms. Thirty patients with TMD and temporomandibular joint pain more severe than 40 mm on the 100-mm visual analog scale (VAS) and aged 19–70 years will be recruited and randomly allocated to either TEA or usual care groups. The TEA group will receive treatment at 14 predefined acupoints once weekly for 4 weeks. The usual care group will receive physical therapy consisting of transcutaneous electrical nerve stimulation and infrared therapy. The average VAS score over the last week for temporomandibular pain after four sessions will be assessed as the primary outcome. Furthermore, maximum pain VAS, vertical opening movement, Graded Chronic Pain version 2, Jaw Functional Limitation Scale 20, Patient Global Impression of Change, Korean version of Beck’s Depression Index, Short Form-12 Health Survey, EuroQol 5-Dimension 5-level, treatment expectation, rescue medication consumption, adverse events, and medical costs for economic evaluation will be measured and analyzed as secondary outcomes during four follow-up visits and after the termination of all sessions. CONCLUSION: The results of this trial will help evaluate the feasibility of a confirmatory RCT considering efficacy, safety, and cost-effectiveness and verify the effect size required to determine an appropriate sample size. TRIAL REGISTRATION NUMBER: KCT0007421. Dove 2022-10-13 /pmc/articles/PMC9576803/ /pubmed/36267351 http://dx.doi.org/10.2147/JPR.S383965 Text en © 2022 Kim et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Study Protocol
Kim, Jung-Hyun
Kang, Dahae
Kim, Koh-Woon
Nam, Sang-Soo
Goo, Bonhyuk
Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial
title Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial
title_full Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial
title_fullStr Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial
title_full_unstemmed Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial
title_short Thread Embedding Acupuncture for Temporomandibular Disorder: Protocol for a Pilot Randomized Controlled Trial
title_sort thread embedding acupuncture for temporomandibular disorder: protocol for a pilot randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576803/
https://www.ncbi.nlm.nih.gov/pubmed/36267351
http://dx.doi.org/10.2147/JPR.S383965
work_keys_str_mv AT kimjunghyun threadembeddingacupuncturefortemporomandibulardisorderprotocolforapilotrandomizedcontrolledtrial
AT kangdahae threadembeddingacupuncturefortemporomandibulardisorderprotocolforapilotrandomizedcontrolledtrial
AT kimkohwoon threadembeddingacupuncturefortemporomandibulardisorderprotocolforapilotrandomizedcontrolledtrial
AT namsangsoo threadembeddingacupuncturefortemporomandibulardisorderprotocolforapilotrandomizedcontrolledtrial
AT goobonhyuk threadembeddingacupuncturefortemporomandibulardisorderprotocolforapilotrandomizedcontrolledtrial